Eicosatetraynoic acid

Phase of research

Potential treatment - theoretical effect

How it helps

Other treatment

Drug status

Experimental

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

Eicosatetraynoic acid is an unsaturated fatty acid acting as an inhibitor on conversion of arachidonic acid to E(2) and F(2a) prostaglandins (MeSH).

Eicosatetraynoic acid on PubChem
Eicosatetraynoic acid on Wikipedia


Synonyms

ETYA; 5,8,11,14-Eicosatetraynoic acid

 

Structure image - Eicosatetraynoic acid

CCCCCC#CCC#CCC#CCC#CCCCC(=O)O


Supporting references

Link Tested on Impact factor Notes Publication date
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
in silico 4.86

In silico screening of potential ACE2 agonists. Theoretical amelioration of ACE2 depletion by virus attachment.

Jun/27/2020